Previous 10 | Next 10 |
Second Sight Medical Products ([[EYES]] +6.9%) is trading higher on the news of a patent granted to the company by the European Patent Office ((EPO)).The patent titled “Cortical interface with an electrode array divided into separate fingers and/or with a wireless transceiver” h...
Grant proceeds support ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form ...
Gainers: Curis (CRIS) +53%.Second Sight Medical Products (EYES) +44%.Summit Wireless Technologies (WISA) +39%.Barnwell Industries (BRN) +36%.Autolus Therapeutics (AUTL) +31%.Ra Medical Systems (RMED) +29%.ShotSpotter (SSTI) +23%.Ideal Power (IPWR) +22%.Minerva Neurosciences (NE...
3 Penny Stocks to Watch Moving Big In Early Morning Trading Moving further into May, there are plenty of penny stocks to watch. But, as smart investors, we need to be picky about which penny stocks go into our portfolios. And right now, that pickiness means that investors should hav...
Second Sight Medical Products (EYES) +24% on reporting two-year results of its Orion study.Upstart Holdings (UPST) +23% on Q1 results.Minerva Neurosciences (NERV) +23% on Q1 results.fuboTV Inc. (FUBO) +21% on Q1 results.Biomerica (BMRA) +17%.Lucira Health (LHDX) +16% ...
Second Sight Medical Products (EYES) gains 7% premarket after announcing two-year results of its Early Feasibility Study of the Orion Visual Cortical Prosthesis (Orion).The Study was paused due to the COVID-19 pandemic, but is now resumed and, is a six subject trial.All subjects are...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced two...
Second Sight Medical Products (EYES) has filed a preliminary prospectus for the sale of 4.65M common shares.Price and oher terms have yet to be determined.Shares down 8.2% premarket trading at $7.53.In late March, the company inked securities purchase deal for 4.65M shares, for gros...
Nxt-ID (NXTD) -16% on FY earnings releaseWilhelmina International (WHLM) -14%.PHX Minerals (PHX) -14% after stock offering for $12M asset purchase.SG Blocks (SGBX) -13% on Q4 earnings release.Blonder Tongue Laboratories (BDR) %.Globalstar (GSAT) -9%.HEXO (HEXO)...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short-covering has become one of the hottest buzzwords of the year after Reddit forum, WallStreetBets, drove a monster rally in heavily shorted shares of Gamestop (NYSE: GME ) from $11 to $483 in days. “Risin...
News, Short Squeeze, Breakout and More Instantly...
Second Sight Medical Products Inc. Company Name:
EYES Stock Symbol:
NASDAQ Market:
Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...
Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...